David V. Smith - Jun 6, 2024 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Director
Signature
/s/ Brian Burkavage, Attorney-in-Fact for David V. Smith
Stock symbol
IOBT
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 04:19 PM
Previous filing
Jun 15, 2023
Next filing
Jun 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +45.6K $0.00 45.6K Jun 6, 2024 Common Stock 45.6K $1.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.